Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,025 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,159
Recruiting: 665
Ph III recruiting: 61
Growth YoY: +9%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (560)

clinicaltrialsPublishedShowing 51–100 of 394 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05010434	Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma	unknown	Phase 2	46	Sun Yat-sen UniversityOTHER	1	Sep 21, 2023	clinicaltrials
NCT06013943	Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC	unknown	Phase 2	30	Eastern Hepatobiliary Surgery HospitalOTHER	1	Sep 15, 2023	clinicaltrials